Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;29(4):517-23.
doi: 10.1007/s40620-016-0333-2. Epub 2016 Jul 9.

FSGS: from pathogenesis to the histological lesion

Affiliations
Review

FSGS: from pathogenesis to the histological lesion

Andrea Angioi et al. J Nephrol. 2016 Aug.

Abstract

Focal and segmental glomerulosclerosis (FSGS) is a generic term that in the current terminology can be appropriate for identifying two conditions. First, a morphological pattern of injury characterized by the occlusion of a single or group of glomerular capillary loops by sclerotic material, indicating a precise histological lesion but with a wide range of etiological interpretations. Second, a pauci-immune renal disease called idiopathic or primary FSGS, which is a podocytopathy triggered by an endogenous cytotoxin that recognizes the podocyte as its sole target. Based on the current and past literature, we do not possess practical tools to easily provide a precise classification of an FSGS lesion, although some clues may be of help in everyday clinical practice. Reactive forms, genetic forms, adaptive forms, forms associated with a deregulation of the proliferation and forms secondary to local glomerular inflammation are the etiological classes known to be associated with the development of an FSGS lesion. However, diagnosing each single case based on clinical, serological and histological criteria is still far from easy and mostly depends on the experience of the renal team, which should involve skilled nephrologists and pathologists.

Keywords: Classification; FSGS; Glomerulopathies; Pathogenesis.

PubMed Disclaimer

References

    1. J Nephrol. 2016 Aug;29(4):525-34 - PubMed
    1. Clin J Am Soc Nephrol. 2007 May;2(3):529-42 - PubMed
    1. Adv Chronic Kidney Dis. 2014 Sep;21(5):400-7 - PubMed
    1. J Pathol. 2000 Mar;190(4):478-83 - PubMed
    1. Kidney Int. 1992 Jul;42(1):136-47 - PubMed

MeSH terms

LinkOut - more resources